verified SJR 0,747 · Q2 • database Scopus / SJR & Web of Science indexed

United Kingdom · Informa Healthcare

workspace_premium Q2 — Medicine (miscellaneous) lock Subscription

COPD: Journal of Chronic Obstructive Pulmonary Disease

COPD: Journal of Chronic Obstructive Pulmonary Disease is a journal indexed in SJR in Medicine (miscellaneous) and Pulmonary and Respiratory Medicine with an H index of 76. It has a price of 2395 €. It has an SJR impact factor of 0,747 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,747.

ISSN: 1541-2555

Publisher: Informa Healthcare

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,747 Q2

H-index 76

Acceptance rate pie_chart

28% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.395 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,747

H-index

Docs (year)

Docs 3y

156

Total refs

1743

Cites 3y

409

Citable 3y

152

Cites/Doc 2y

2.29

Ref/Doc

47.11

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Association between Sarcopenia and Metabolic Syndrome in Chronic Obstructive Pulmonary Disease: The Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011

Ventilation Distribution Heterogeneity at Rest as a Marker of Exercise Impairment in Mild-to-Advanced COPD

Clinical Safety of Long-Acting beta2-Agonist and Inhaled Corticosteroid Combination Therapy in COPD

Chronic Obstructive Pulmonary Disease Illness and Medication Beliefs are Associated with Medication Adherence

Chronic Effort Dyspnea Explained by Lung Function Tests and by HRCT and CRX Radiographic Patterns in COPD: A Post-Hoc Analysis in 51 Patients

Changes in the Superior Vena Cava Area During Inspiration and Expiration in Relation to Emphysema

Cardiovascular Safety of QVA149, a Combination of Indacaterol and NVA237, in COPD Patients

Cardiac Troponin-I Predicts Long-Term Mortality in Chronic Obstructive Pulmonary Disease

Cardiac Sympathetic Hyperactivity in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea

Cardiac Sympathetic Dominance and Systemic Inflammation in COPD

beta2-Agonists Potentiate Corticosteroid-Induced Neutrophil Survival

Average Age at Death from COPD in the United States: 1980-85, 1990-95, 2000-05

SHOW MORE ARTICLES

Augmentation Therapy in Alpha-1 Antitrypsin Deficiency

3-chlorotyrosine in Sputum of COPD Patients: Relationship with Airway Inflammation

Antioxidant Diet Protects Against Emphysema, but Increases Mortality in Cigarette Smoke-Exposed Mice

An International Comparison of Pulmonary Rehabilitation: A Systematic Review

Alveolar Macrophages as Orchestrators of COPD

Alpha1-antitrypsin deficiency: the contribution of national registries to the understanding of the disorder. A journal Supplement in memory of Professor Maurizio Luisetti

Alpha-1 Antitrypsin Deficiency: Doing the Right Thing (or Start Kissing Those Frogs)

AIR 2008 Conference

Age and Disease have a Distinct Influence on Postural Balance of Patients with COPD

African Americans and Men with Severe COPD Have a High Prevalence of Osteoporosis

Activities of Life: The COPD Patient

A Review of the Role of FEV1in the COPD Paradigm

FAQs

COPD: Journal of Chronic Obstructive Pulmonary Disease has an SJR of 0,747 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 2395 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for COPD: Journal of Chronic Obstructive Pulmonary Disease is 28%.

COPD: Journal of Chronic Obstructive Pulmonary Disease

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of COPD: Journal of Chronic Obstructive Pulmonary Disease?

What is the APC / publication cost?

What is the acceptance rate?